CD55 and CD59, but not CD46, are involved in the hyperactivation and deposition of the complement factors C3, C3b/iC3b/C3d and C5b-9 in infected lung lesions of coronavirus disease 2019 (COVID-19)-affected people. The gene discussed is CD46; the disease is COVID-19.